Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-24-005571

CHIEF MEDICAL OFFICER sold 511 shares at $19.50 ($9,965)

  • CHIEF MEDICAL OFFICER acquired 511 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gillies Hunter · CHIEF MEDICAL OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-23 Exercise or conversion : show line 1 in the form 10b5-1 +511 $1.74 $889 3,762 D
2024-02-23 Sale : show line 2 in the form 10b5-1 −511 $19.50 $9,965 3,251 D
Open-market sales · 511 sh · avg $19.50 · $9,965

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-23 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −511 3,014 D
Loading xslF345X05/form4-02272024_060201.xml…